Adverse events and complications after magnetic resonance-guided focused ultrasound (MRgFUS) therapy in uterine fibroids – a systematic review and future perspectives

References

• Bulun SE. Uterine fibroids. N Engl J Med. 2013;369(14):1344–1355.
   PubMed Web of Science ®Google Scholar
• Ciarmela P, Islam MS, Reis FM, et al. Growth factors and myometrium: biological effects in uterine fibroid and possible clinical implications. Hum Reprod Update. 2011;17(6):772–790.
   PubMed Web of Science ®Google Scholar
• Stewart EA, Cookson CL, Gandolfo RA, et al. Epidemiology of uterine fibroids: a systematic review. BJOG. 2017;124(10):1501–1512.
   PubMed Web of Science ®Google Scholar
• Qin H, Lin Z, Vásquez E, et al. Association between obesity and the risk of uterine fibroids: a systematic review and meta-analysis. J Epidemiol Community Health. 2021;75(2):197–204.
   PubMed Web of Science ®Google Scholar
• Parker WH. Etiology, symptomatology, and diagnosis of uterine myomas. Fertil Steril. 2007;87(4):725–736.
   PubMed Web of Science ®Google Scholar
• Zimmermann A, Bernuit D, Gerlinger C, et al. Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women. BMC Womens Health. 2012;12:6.
   PubMed Web of Science ®Google Scholar
• Al-Hendy A, Myers ER, Stewart E. Uterine fibroids: burden and unmet medical need. Semin Reprod Med. 2017;35(6):473–480.
   PubMed Web of Science ®Google Scholar
• Riggan KA, Stewart EA, Balls-Berry JE, et al. Patient recommendations for shared decision-making in uterine fibroid treatment decisions. J Patient Exp. 2021;8:23743735211049655.
   Google Scholar
• Dolmans MM, Donnez J, Fellah L. Uterine fibroid management: today and tomorrow. J Obstet Gynaecol Res. 2019;45(7):1222–1229.
   PubMed Web of Science ®Google Scholar
• West CP, Lumsden MA, Lawson S, et al. Shrinkage of uterine fibroids during therapy with goserelin (Zoladex): a luteinizing hormone-releasing hormone agonist administered as a monthly subcutaneous depot. Fertil Steril. 1987;48(1):45–51.
   PubMed Web of Science ®Google Scholar
• Farris M, Bastianelli C, Rosato E, et al. Uterine fibroids: an update on current and emerging medical treatment options. Ther Clin Risk Manag. 2019;15:157–178.
   PubMed Web of Science ®Google Scholar
• Donnez J, Arriagada P, Marciniak M, et al. Liver safety parameters of ulipristal acetate for the treatment of uterine fibroids: a comprehensive review of the clinical development program. Expert Opin Drug Saf. 2018;17(12):1225–1232.
   PubMed Web of Science ®Google Scholar
• Al-Hendy A, Lukes AS, Poindexter AN, 3rd, et al. Treatment of uterine fibroid symptoms with relugolix combination therapy. N Engl J Med. 2021;384(7):630–642.
   PubMed Web of Science ®Google Scholar
• Vilos GA, Allaire C, Laberge PY, et al. The management of uterine leiomyomas. J Obstet Gynaecol Can. 2015;37(2):157–178.
   PubMed Web of Science ®Google Scholar
• Boyd LR, Novetsky AP, Curtin JP. Effect of surgical volume on route of hysterectomy and short-term morbidity. Obstet Gynecol. 2010;116(4):909–915.
   PubMed Web of Science ®Google Scholar
• Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. J Clin Epidemiol. 2021;134:178–189.
   PubMed Web of Science ®Google Scholar
• Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
   PubMed Web of Science ®Google Scholar
• Wells G, Shea B, O'Connell D, et al. The Newcastle–Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analysis. 2000.
   Google Scholar
• Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.
   PubMed Web of Science ®Google Scholar
• Inbar Y, Machtinger R, Barnett-Itzhaki Z, et al. MRI guided focused ultrasound (MRgFUS) treatment for uterine fibroids among women with and without abdominal scars. Int J Hyperthermia. 2021;38(1):1672–1676.
   PubMed Web of Science ®Google Scholar
• Browne JE, Gorny KR, Hangiandreou NJ, et al. Comparison of clinical performance between two generations of magnetic resonance-guided focused ultrasound systems in treatments of uterine leiomyomas. Acad Radiol. 2021;28(10):1361–1367.
   PubMed Web of Science ®Google Scholar
• Verpalen IM, van 't Veer-Ten Kate M, de Boer E, et al. Development and clinical evaluation of a 3-step modified manipulation protocol for MRI-guided high-intensity focused ultrasound of uterine fibroids. Eur Radiol. 2020;30(7):3869–3878.
   PubMed Web of Science ®Google Scholar
• Verpalen IM, de Boer JP, Linstra M, et al. The focused ultrasound myoma outcome study (FUMOS); a retrospective cohort study on long-term outcomes of MR-HIFU therapy. Eur Radiol. 2020;30(5):2473–2482.
   PubMed Web of Science ®Google Scholar
• Keserci B, Duc NM, Nadarajan C, et al. Volumetric MRI-guided, high-intensity focused ultrasound ablation of uterine leiomyomas: ASEAN preliminary experience. Diagn Interv Radiol. 2020;26(3):207–215.
   PubMed Web of Science ®Google Scholar
• Sinha V, Mehta S, Kalantzis G, et al. Artifact from myomectomy/C-Section on MRI images - what does this mean for MR-guided focused ultrasound candidacy for uterine fibroids? Int J Hyperthermia. 2019;36(1):1079–1083.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang ZB, Xu YH. Efficacy, efficiency, and safety of magnetic resonance-guided high-intensity focused ultrasound for ablation of uterine fibroids: comparison with ultrasound-Guided method. Korean J Radiol. 2018;19(4):724–732.
   PubMed Web of Science ®Google Scholar
• Barnard EP, AbdElmagied AM, Vaughan LE, et al. Periprocedural outcomes comparing fibroid embolization and focused ultrasound: a randomized controlled trial and comprehensive cohort analysis. Am J Obstet Gynecol. 2017;216(5):500.e1–500.e11.
   PubMed Web of Science ®Google Scholar
• Tung SL, Chou TY, Tseng HS, et al. A retrospective study of magnetic resonance-guided focused ultrasound ablation for uterine myoma in Taiwan. Taiwan J Obstet Gynecol. 2016;55(5):646–649.
   PubMed Web of Science ®Google Scholar
• Jacoby VL, Kohi MP, Poder L, et al. PROMISe trial: a pilot, randomized, placebo-controlled trial of magnetic resonance guided focused ultrasound for uterine fibroids. Fertil Steril. 2016;105(3):773–780.
   PubMed Web of Science ®Google Scholar
• Chen R, Keserci B, Bi H, et al. The safety and effectiveness of volumetric magnetic resonance-guided high-intensity focused ultrasound treatment of symptomatic uterine fibroids: early clinical experience in China. J Ther Ultrasound. 2016;4:27.
   PubMed Web of Science ®Google Scholar
• Xu Y, Fu Z, Yang L, et al. Feasibility, safety, and efficacy of accurate uterine fibroid ablation using magnetic resonance imaging-guided high-intensity focused ultrasound with shot sonication. J Ultrasound Med. 2015;34(12):2293–2303.
   PubMed Web of Science ®Google Scholar
• Thiburce AC, Frulio N, Hocquelet A, et al. Magnetic resonance-guided high-intensity focused ultrasound for uterine fibroids: mid-term outcomes of 36 patients treated with the sonalleve system. Int J Hyperthermia. 2015;31(7):764–770.
   PubMed Web of Science ®Google Scholar
• Mindjuk I, Trumm CG, Herzog P, et al. MRI predictors of clinical success in MR-guided focused ultrasound (MRgFUS) treatments of uterine fibroids: results from a single centre. Eur Radiol. 2015;25(5):1317–1328.
   PubMed Web of Science ®Google Scholar
• Ikink ME, Van Breugel JMM, Schubert G, et al. Volumetric MR-guided high-intensity focused ultrasound with direct skin cooling for the treatment of symptomatic uterine fibroids: proof-of-Concept study. Biomed Res Int. 2015;2015:684250.
   PubMed Web of Science ®Google Scholar
• Quinn SD, Vedelago J, Gedroyc W, et al. Safety and five-year re-intervention following magnetic resonance-guided focused ultrasound (MRgFUS) for uterine fibroids. Eur J Obstet Gynecol Reprod Biol. 2014;182:247–251.
   PubMed Web of Science ®Google Scholar
• Park MJ, Kim YS, Rhim H, et al. Safety and therapeutic efficacy of complete or near-complete ablation of symptomatic uterine fibroid tumors by MR imaging-guided high-intensity focused US therapy. J Vasc Interv Radiol. 2014;25(2):231–239.
   PubMed Web of Science ®Google Scholar
• Trumm CG, Stahl R, Clevert DA, et al. Magnetic resonance imaging-guided focused ultrasound treatment of symptomatic uterine fibroids: impact of technology advancement on ablation volumes in 115 patients. Invest Radiol. 2013;48(6):359–365.
   PubMed Web of Science ®Google Scholar
• Ruhnke H, Eckey T, Bohlmann MK, et al. MR-guided HIFU treatment of symptomatic uterine fibroids using novel feedback-regulated volumetric ablation: effectiveness and clinical practice. Rofo. 2013;184(10):983–991.
   PubMedGoogle Scholar
• Quinn SD, Vedelago J, Regan L, et al. Safety and treatment volumes achieved following new developments of the magnetic resonance-guided focused ultrasound system in the treatment of uterine fibroids: a cohort study. J Ther Ultrasound. 2013;1:20.
   PubMedGoogle Scholar
• Machtinger R, Fennessy FM, Stewart EA, et al. MR-guided focused ultrasound (MRgFUS) is effective for the distinct pattern of uterine fibroids seen in African-American women: data from phase III/IV, non-randomized, multicenter clinical trials. J Ther Ultrasound. 2013;1:23.
   PubMedGoogle Scholar
• Dorenberg EJ, Courivaud F, Ring E, et al. Volumetric ablation of uterine fibroids using Sonalleve high-intensity focused ultrasound in a 3 Tesla scanner-first clinical assessment. Minim Invasive Ther Allied Technol. 2013;22(2):73–79.
   PubMed Web of Science ®Google Scholar
• Brown DL, Hesley GK, Gorny KR, et al. Safety of MR-guided focused ultrasound treatment of pedunculated subserosal uterine leiomyomas. J Ther Ultrasound. 2013;1(1):19.
   Google Scholar
• Voogt MJ, Trillaud H, Kim YS, et al. Volumetric feedback ablation of uterine fibroids using magnetic resonance-guided high intensity focused ultrasound therapy. Eur Radiol. 2012;22(2):411–417.
   PubMed Web of Science ®Google Scholar
• Venkatesan AM, Partanen A, Pulanic TK, et al. Magnetic resonance imaging-guided volumetric ablation of symptomatic leiomyomata: correlation of imaging with histology. J Vasc Interv Radiol. 2012;23(6):786–794.e4.
   PubMed Web of Science ®Google Scholar
• Park H, Yoon SW, Kim KA, et al. Magnetic resonance imaging-guided focused ultrasound treatment of pedunculated subserosal uterine fibroids: a preliminary report. J Vasc Interv Radiol. 2012;23(12):1589–1593.
   PubMed Web of Science ®Google Scholar
• Kim YS, Kim JH, Rhim H, et al. Volumetric MR-guided high-intensity focused ultrasound ablation with a one-layer strategy to treat large uterine fibroids: initial clinical outcomes. Radiology. 2012;263(2):600–609.
   PubMed Web of Science ®Google Scholar
• Desai SB, Patil AA, Nikam R, et al. Magnetic resonance-guided focused ultrasound treatment for uterine fibroids: first study in Indian women. J Clin Imaging Sci. 2012;2:74.
   PubMedGoogle Scholar
• Yoon SW, Seong SJ, Jung SG, et al. Mitigation of abdominal scars during MR-guided focused ultrasound treatment of uterine leiomyomas with the use of an energy-blocking scar patch. J Vasc Interv Radiol. 2011;22(12):1747–1750.
   PubMed Web of Science ®Google Scholar
• Kim HS, Baik JH, Pham LD, et al. MR-guided high-intensity focused ultrasound treatment for symptomatic uterine leiomyomata: long-term outcomes. Acad Radiol. 2011;18(8):970–976.
   PubMed Web of Science ®Google Scholar
• Zhang L, Chen WZ, Liu YJ, et al. Feasibility of magnetic resonance imaging-guided high intensity focused ultrasound therapy for ablating uterine fibroids in patients with bowel lies anterior to uterus. Eur J Radiol. 2010;73(2):396–403.
   PubMed Web of Science ®Google Scholar
• Zaher S, Gedroyc W, Lyons D, et al. A novel method to aid in the visualisation and treatment of uterine fibroids with MRgFUS in patients with abdominal scars. Eur J Radiol. 2010;76(2):269–273.
   PubMed Web of Science ®Google Scholar
• Taran FA, Tempany CM, Regan L, MRgFUS Group, et al. Magnetic resonance-guided focused ultrasound (MRgFUS) compared with abdominal hysterectomy for treatment of uterine leiomyomas. Ultrasound Obstet Gynecol. 2009;34(5):572–578.
   PubMed Web of Science ®Google Scholar
• Okada A, Morita Y, Fukunishi H, et al. Non-invasive magnetic resonance-guided focused ultrasound treatment of uterine fibroids in a large Japanese population: impact of the learning curve on patient outcome. Ultrasound Obstet Gynecol. 2009;34(5):579–583.
   PubMed Web of Science ®Google Scholar
• Morita Y, Takeuchi S, Hikida H, et al. Decreasing margins to the uterine serosa as a method for increasing the volume of fibroids ablated with magnetic resonance-guided focused ultrasound surgery. Eur J Obstet Gynecol Reprod Biol. 2009;146(1):92–95.
   PubMed Web of Science ®Google Scholar
• Morita Y, Ito N, Hikida H, et al. Non-invasive magnetic resonance imaging-guided focused ultrasound treatment for uterine fibroids - early experience. Eur J Obstet Gynecol Reprod Biol. 2008;139(2):199–203.
   PubMed Web of Science ®Google Scholar
• Funaki K, Sawada K, Maeda F, et al. Subjective effect of magnetic resonance-guided focused ultrasound surgery for uterine fibroids. J Obstet Gynaecol Res. 2007;33(6):834–839.
   PubMed Web of Science ®Google Scholar
• Fennessy FM, Tempany CM, McDannold NJ, et al. Uterine leiomyomas: MR imaging-guided focused ultrasound surgery–results of different treatment protocols. Radiology. 2007;243(3):885–893.
   PubMed Web of Science ®Google Scholar
• Stewart EA, Rabinovici J, Tempany CM, et al. Clinical outcomes of focused ultrasound surgery for the treatment of uterine fibroids. Fertil Steril. 2006;85(1):22–29.
   PubMed Web of Science ®Google Scholar
• Smart OC, Hindley JT, Regan L, et al. Magnetic resonance guided focused ultrasound surgery of uterine fibroids–the tissue effects of GnRH agonist pre-treatment. Eur J Radiol. 2006;59(2):163–167.
   PubMed Web of Science ®Google Scholar
• Smart OC, Hindley JT, Regan L, et al. Gonadotrophin-releasing hormone and magnetic-resonance-guided ultrasound surgery for uterine leiomyomata. Obstet Gynecol. 2006;108(1):49–54.
   PubMed Web of Science ®Google Scholar
• Hindley J, Gedroyc WM, Regan L, et al. MRI guidance of focused ultrasound therapy of uterine fibroids: early results. Am J Roentgenol. 2004;183(6):1713–1719.
   PubMed Web of Science ®Google Scholar
• Stewart EA, Gedroyc WM, Tempany CM, et al. Focused ultrasound treatment of uterine fibroid tumors: safety and feasibility of a noninvasive thermoablative technique. Am J Obstet Gynecol. 2003;189(1):48–54.
   PubMed Web of Science ®Google Scholar
• Gorny KR, Woodrum DA, Brown DL, et al. Magnetic resonance-guided focused ultrasound of uterine leiomyomas: review of a 12-month outcome of 130 clinical patients. J Vasc Interv Radiol. 2011;22(6):857–864.
   PubMed Web of Science ®Google Scholar
• Verpalen IM, Anneveldt KJ, Nijholt IM, et al. Magnetic resonance-high intensity focused ultrasound (MR-HIFU) therapy of symptomatic uterine fibroids with unrestrictive treatment protocols: a systematic review and meta-analysis. Eur J Radiol. 2019;120:108700.
   PubMed Web of Science ®Google Scholar
• Williamson A, Hoggart B. Pain: a review of three commonly used pain rating scales. J Clin Nurs. 2005;14(7):798–804.
   PubMed Web of Science ®Google Scholar
• Khalilzadeh O, Baerlocher MO, Shyn PB, et al. Proposal of a new adverse event classification by the society of interventional radiology standards of practice committee. J Vasc Interv Radiol. 2017;28(10):1432–1437.e3.
   PubMed Web of Science ®Google Scholar
• Toor SS, Jaberi A, Macdonald DB, et al. Complication rates and effectiveness of uterine artery embolization in the treatment of symptomatic leiomyomas: a systematic review and meta-analysis. Am J Roentgenol. 2012;199(5):1153–1163.
   PubMed Web of Science ®Google Scholar
• Clarke-Pearson DL, Geller EJ. Complications of hysterectomy. Obstet Gynecol. 2013;121(3):654–673.
   PubMed Web of Science ®Google Scholar
• Ikink ME, Nijenhuis RJ, Verkooijen HM, et al. Volumetric MR-guided high-intensity focused ultrasound versus uterine artery embolisation for treatment of symptomatic uterine fibroids: comparison of symptom improvement and reintervention rates. Eur Radiol. 2014;24(10):2649–2657.
   PubMed Web of Science ®Google Scholar